A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy.
Ontology highlight
ABSTRACT: After a two-decade hiatus in which research on psychedelics was essentially halted, placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions have begun to be published. We identified nine randomized, placebo-controlled clinical trials of psychedelic-assisted therapy published since 1994. Studies examined psilocybin, LSD (lysergic acid diethylamide), ayahuasca (which contains a combination of N,N-dimethyltryptamine and harmala monoamine oxidase inhibitor alkaloids), and MDMA (3,4-methylenedioxymethamphetamine). We compared the standardized mean difference between the experimental and placebo control group at the primary endpoint. Results indicated a significant mean between-groups effect size of 1.21 (Hedges g), which is larger than the typical
SUBMITTER: Luoma JB
PROVIDER: S-EPMC7736164 | biostudies-literature | 2020 Sep-Oct
REPOSITORIES: biostudies-literature
ACCESS DATA